Synthetic Biologics, Inc.
Beta-lactamases with improved properties for therapy
Last updated:
Abstract:
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Status:
Grant
Type:
Utility
Filling date:
24 Jul 2020
Issue date:
1 Feb 2022